Bristol-Myers Squibb Co
BMY
$44.23+0.92 (+2.12%)
Aug 2, 2025, 4:00 PM
Financials
| 52Week High | 63.33 | 52Week Low | 42.96 |
| Beta | 0.34 | Current Ratio Annual | 1.25 |
| Current Ratio Quarterly | 1.28 | Gross Margin TTM | 74.69 |
| Market Cap | 90.01B | Net Profit Margin TTM | 11.38 |
| Operating Margin TTM | 16.78 | Price To Book | 5.18 |
| Price To Earnings TTM | 16.61 | Price To Free Cash Flow TTM | 6.88 |
| Price To Sales TTM | 1.89 | Quick Ratio Annual | 1.15 |
| Quick Ratio Quarterly | 1.17 | Return On Assets TTM | 5.81 |
| Return On Equity TTM | 31.93 | Return On Investment TTM | 8.05 |
| Revenue Growth3Y | 1.36 | Revenue Growth5Y | 13.06 |
| Revenue Growth Quarterly Yoy | -5.60 | Revenue Growth TTMYoy | 4.62 |
| Revenue Per Share TTM | 23.35 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 2351 | 165 | 253 | 897 | 931 | 318 | 1.64B | $95.80B |
| Jun 30, 2025 | 1017 | 33 | 119 | 315 | 440 | 140 | 116.87M | $4.76B |
| Change | 1.33K(57%) | 132(80%) | 134(53%) | 582(65%) | 491(53%) | 178(56%) | 1.52B(93%) | $91.05B(95%) |